Sarah Seiler

发表

FGF-23: the rise of a novel cardiovascular risk marker in CKD.

D. Fliser, G. Heine, S. Seiler, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.

D. Fliser, M. Böhm, G. Heine, 2011, European heart journal.

Clinical relevance of FGF-23 in chronic kidney disease.

D. Fliser, G. Heine, S. Seiler, 2009, Kidney international. Supplement.

Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.

D. Fliser, J. Floege, S. Neuhaus, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Measurement of serum soluble Klotho levels in CKD 5D patients: useful tool or dispensable biomarker?

D. Fliser, G. Heine, M. Ketteler, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.

D. Fliser, G. Heine, H. Roth, 2013, Kidney international.

HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.

W. März, M. Kleber, H. Scharnagl, 2014, Journal of the American Society of Nephrology : JASN.

FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock

D. Fliser, M. Böhm, F. Mahfoud, 2013, European heart journal. Acute cardiovascular care.

CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.

B. Cremers, A. Zawada, G. Heine, 2012, Journal of the American College of Cardiology.

CD14 CD16 Monocytes Independently Predict Cardiovascular Events

D. Fliser, N. Binder, M. Böhm, 2012 .

Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.

S. Blankenberg, D. Fliser, K. Lackner, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.

D. Fliser, G. Heine, E. Seibert, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Comparison of two different strategies for human monocyte subsets gating within the large‐scale prospective CARE FOR HOMe Study

D. Fliser, A. Zawada, Lisa H. Fell, 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Lower Apo A-I and Lower HDL-C Levels Are Associated With Higher Intermediate CD14++CD16+ Monocyte Counts That Predict Cardiovascular Events in Chronic Kidney Disease

D. Fliser, M. Böhm, G. Heine, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients.

M. Ziegler, M. Klingele, D. Fliser, 2013, Clinical journal of the American Society of Nephrology : CJASN.

CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients.

A. Schlitt, J. Marell, G. Heine, 2008, Kidney international.

CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.

D. Fliser, G. Heine, A. Zawada, 2011, European heart journal.

CD 14 11 CD 16 1 monocytes and cardiovascular outcome in patients with chronic kidney disease

D. Fliser, G. Heine, A. Zawada, 2010 .

Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.

D. Fliser, D. Raj, M. Wing, 2014, Atherosclerosis.

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

G. Schuler, H. Thiele, M. Böhm, 2014, Critical Care.

Carbamylated low-density lipoprotein induces endothelial dysfunction.

A. Akhmedov, L. Rohrer, T. Lüscher, 2014, European heart journal.

Ultrasound renal resistive index is not an organ-specific predictor of allograft outcome.

M. Ziegler, D. Fliser, G. Lucisano, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation incorporating both cystatin C and creatinine best predicts individual risk: a cohort study in 444 patients with chronic kidney disease.

J. Pickering, D. Fliser, G. Heine, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss – a case report

M. Klingele, D. Fliser, P. Lepper, 2014, BMC Nephrology.

Distinct immunologic effects of different intravenous iron preparations on monocytes

D. Fliser, G. Heine, A. Zawada, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.